An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

NCT04742699 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Lemborexant (LEM) 5 mg (Z-Drug-mono cohort)
DRUG: Lemborexant (LEM) 5 mg (SUV-mono cohort)
DRUG: Lemborexant (LEM) 5 mg (SUV-combination cohort)
DRUG: Lemborexant (LEM) 5 mg (RMT-combination cohort)

Sponsor

Kurume University

Collaborators

[object Object]
[object Object]